Biomedical Research - Research Centers (RC)

Active

Assistance listing
93.GM5
Agency
Grant awards
Not on record

Program facts

Treasury account
  • 75-0897-0-1-552
More information

Program details come from SAM.gov Assistance Listings. Updated .

About this program

The National Institute of General Medical Sciences (NIGMS), a component of the National Institutes of Health within the Department of Health and Human Services, funds basic biomedical research that advances understanding of biological processes and supports disease diagnosis, treatment, and prevention through the Research Centers program (CFDA 93.GM5).

The source provided does not include a grant award portfolio block, recent grant awards, or open grant opportunities with due dates. Consequently, current award activity, funding magnitudes, recent recipient examples, and assistance-type distribution cannot be determined from this source. The program description emphasizes peer-review-driven merit evaluation and indicates that NIGMS considers portfolio breadth, investigator status (early-stage and at-risk), and existing investigator support when making funding decisions. The Institute prioritizes support for meritorious investigators lacking substantial existing funding and generally limits investigators to one NIGMS R01 grant (including multi-PI R01s), while prioritizing the MIRA program over R01 awards according to its strategic plan. Budget levels are determined individually based on scientific merit, existing support for the principal investigator's laboratory, and Institute budgetary constraints; applicants are advised not to assume awarded amounts will match study section recommendations. Eligible applicants are described in the relevant Notice of Funding Opportunity (NOFO); specific eligibility constraints are not detailed in the source material provided.

To assess current pursuit viability, obtain the most recent NOFO posting, which will specify open application deadlines, allowable budget ranges, eligible applicant categories, and representative recent award data.

Objective and description

Objective

The National Institute of General Medical Sciences (NIGMS) supports basic research that increases our understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. NIGMS also supports rese

Description

The National Institute of General Medical Sciences (NIGMS) supports basic research that increases our understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention.

Eligibility

Applicant eligibility

Description of who is eligible to apply will be published in the NOFO.

How to apply

Criteria for selecting proposals

All accepted applications are reviewed for scientific and technical merit by an appropriate initial review group and by a national advisory council. The goal of NIGMS funding policies is to maximize the scientific impact of investments in investigator-initiated biomedical research to drive fundamental scientific discoveries that advance understanding of human health and disease. To address this goal, the Institute strives to support a broad portfolio of research grants of high scientific and technical merit, as determined by peer review, in its mission areas. However, in deciding to fund any application, NIGMS staff also considers other factors, including (consistent with applicable law): the breadth of the Institute's research portfolio; approaches, and investigators; the total amount of funding available to the investigator; the priority of the research area for the Institute's mission; Early-stage investigator status; At-risk investigator status;and whether the PI would have more than one NIGMS funded R01 (including multi-PI R01s). Because these factors are considered, NIGMS does not have a "payline" or strict cutoff in scores that it will fund. It is important to understand that even applications with outstanding scores might not be funded if the investigator already has substantial other support. Because NIGMS prioritizes funding for meritorious investigators who otherwise would not have support over providing additional grants to already well-funded investigators, the Institute is unlikely to award more than one NIGMS R01 to a PI (including multi-PI R01s). In accordance with our Strategic Plan, NIGMS generally prioritizes funding the MIRA program over R01 awards.

Award procedure

In calculating budgets for grants, NIGMS staff considers each budget carefully and takes into account the science being conducted, the other support for the PI's lab, the Institute's budget, and other factors. PIs should not assume that they will be awarded the amount recommended by the study section. To fund as broad a portfolio of meritorious investigators as soon as possible and to improve overall returns on investments, NIGMS pays close attention to budget levels and gives large budget increases only in highly compelling cases. Applicants are encouraged to contact NIGMS program staff with questions.

Renewals

Determined as part of the NOFO

Appeals

An applicant may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. A description of the NIH Peer Review Appeal procedures is available on the NIH website at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-11-064.html.

Quick answers

What is Assistance Listing 93.GM5?

Assistance Listing 93.GM5 is Biomedical Research - Research Centers (RC), a federal grant program run by National Institutes of Health (Department of Health and Human Services).

What is the CFDA number for Biomedical Research - Research Centers (RC)?

Its CFDA number is 93.GM5: Assistance Listing numbers were called CFDA numbers before 2018.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program